NCT04557059 2026-03-13
PRIMORDIUM
Janssen Pharmaceutica N.V., Belgium
Phase 3 Active not recruiting
Clinical Trials
10 trialsNCT05704985 2025-05-29
Evaluating Safety and Biomarkers Using DK210 (EGFR) for Locally Advanced or Metastatic EGFR+ Tumors
DEKA Biosciences
Phase 1 Active not recruiting
NCT03763851 2020-03-12
Cannabis Oil and Radiation Therapy for the Management of Pain
Tetra Bio-Pharma
Phase 2 Terminated
NCT01496131 2018-03-09
Tecemotide (L-BLP25) in Prostate Cancer
EMD Serono
Phase 2 Completed
NCT00158886 2017-11-14
Oral Topotecan As A Radiosensitizing Agent In Rectal Cancer
GlaxoSmithKline
Phase 1 Terminated
NCT01122121 2015-07-29
Leuprorelin Associated With Radiotherapy Versus Leuprorelin Alone in T3 - T4 or pT3 (on Biopsy) N0, M0 Prostate Cancer
Takeda
Phase 3 Completed
NCT00480623 2012-03-23
A Phase I Trial of Satraplatin Plus Radiation Therapy for Prostate Cancer Patients With Biochemical Recurrence
Agennix
Phase 1 Terminated
NCT00239291 2009-04-23
Safety Study to Explore Combination of Gefitinib (ZD1839, Iressa) and Radiotherapy in Non-Metastatic Prostate Cancer
AstraZeneca
Phase 1/2 Completed
NCT00590213 2008-01-25
COMART
AstraZeneca
Phase 4 Completed
NCT00490880 2007-06-25
Neoadjuvant Chemo (Gemcitabine and Cisplatin) With Radical Cystectomy or Radiotherapy in Patients With Bladder Cancer
Eli Lilly and Company
Phase 2 Completed